fluconazole has been researched along with Tinea Versicolor in 27 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Tinea Versicolor: A common chronic, noninflammatory and usually symptomless disorder, characterized by the occurrence of multiple macular patches of all sizes and shapes, and varying in pigmentation from fawn-colored to brown. It is seen most frequently in hot, humid, tropical regions and is mostly caused by MALASSEZIA FURFUR (formerly Pityrosporum orbiculare).
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to assess the efficacy, tolerability, and safety of oral fluconazole given at 300 mg once weekly for two weeks in the treatment of tinea versicolor." | 9.11 | Oral fluconazole in the treatment of tinea versicolor. ( Durdu, M; Karakaş, M; Memişoğlu, HR, 2005) |
| "In our study of 6 month of pityriasis versicolor patient in skin department of Mymensingh Medical College Hospital outdoor, most of the patient was of age 16-25 years (63." | 6.74 | A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor. ( Islam, N; Islam, T; Kamal, M; Muhammad, N; Shafiquzzaman, M, 2009) |
| "This study was designed to assess the efficacy, tolerability, and safety of oral fluconazole given at 300 mg once weekly for two weeks in the treatment of tinea versicolor." | 5.11 | Oral fluconazole in the treatment of tinea versicolor. ( Durdu, M; Karakaş, M; Memişoğlu, HR, 2005) |
| "The efficacy of BCO was assessed in vitro and compared to that of the drugs currently utilized in the treatment of tinea versicolor (fluconazole and itraconazole) and tinea pedis (itraconazole and terbinafine)." | 3.88 | Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor. ( Carreira, A; Ferreira, J; Ferreira, JB; Ferreira, RB; Filipe, P; Monteiro, S; Pereira, I, 2018) |
| "Our study included all patients with pityriasis versicolor who attended in dermatology department of Habib Thameur Hospital, Tunis (over a 21-month period)." | 2.82 | Comparative clinical trial: fluconazole alone or associated with topical ketoconazole in the treatment of pityriasis versicolor. ( Badri, T; Bzioueche, N; Hammami, H; Mokhtar, I; Zouari, B, 2016) |
| "All consecutive patients with pityriasis versicolor were included and randomly divided into two groups." | 2.75 | Single-dose oral fluconazole versus topical clotrimazole in patients with pityriasis versicolor: A double-blind randomized controlled trial. ( Akbari, N; Alborzi, N; Dehghan, M; Keshtkar, AA; Sadani, S, 2010) |
| "In our study of 6 month of pityriasis versicolor patient in skin department of Mymensingh Medical College Hospital outdoor, most of the patient was of age 16-25 years (63." | 2.74 | A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor. ( Islam, N; Islam, T; Kamal, M; Muhammad, N; Shafiquzzaman, M, 2009) |
| "Ninety patients with extensive pityriasis versicolor (body involved area > or =25%) were randomly assigned to treatment with either a single dose of 400 mg of ketoconazole or with two doses of 300 mg of fluconazole with 2 weeks interval." | 2.73 | Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor. ( Azizi, H; Suizi, B; Yazdanpanah, MJ, 2007) |
| "A total of 40 patients with pityriasis versicolor were allocated randomly to group A and group B." | 2.71 | Single-dose fluconazole versus itraconazole in pityriasis versicolor. ( Chakrabarti, A; Kaur, I; Kumar, B; Partap, R, 2004) |
| "Pityriasis versicolor can be treated by a single or multiple dosage regime of ketoconazole as well as by fluconazole." | 2.70 | Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study. ( Baruah, MC; Bhogal, CS; Singal, A, 2001) |
| "Ketoconazole (1 mg/kg) was effective in all four animals." | 1.27 | Activity of triazole derivatives against Pityrosporum orbiculare in vitro and in vivo. ( Faergemann, J, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.70) | 18.7374 |
| 1990's | 7 (25.93) | 18.2507 |
| 2000's | 12 (44.44) | 29.6817 |
| 2010's | 7 (25.93) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Housiny, S | 1 |
| Shams Eldeen, MA | 1 |
| El-Attar, YA | 1 |
| Salem, HA | 1 |
| Attia, D | 1 |
| Bendas, ER | 1 |
| El-Nabarawi, MA | 1 |
| Carreira, A | 1 |
| Ferreira, JB | 1 |
| Pereira, I | 1 |
| Ferreira, J | 1 |
| Filipe, P | 1 |
| Ferreira, RB | 1 |
| Monteiro, S | 1 |
| Far, FE | 1 |
| Al-Obaidi, MMJ | 1 |
| Desa, MNM | 1 |
| Helou, J | 1 |
| Obeid, G | 1 |
| Moutran, R | 1 |
| Maatouk, I | 1 |
| Badri, T | 1 |
| Hammami, H | 1 |
| Bzioueche, N | 1 |
| Zouari, B | 1 |
| Mokhtar, I | 1 |
| Lai, O | 1 |
| Hsu, S | 1 |
| Muhammad, N | 1 |
| Kamal, M | 1 |
| Islam, T | 1 |
| Islam, N | 1 |
| Shafiquzzaman, M | 1 |
| Dehghan, M | 1 |
| Akbari, N | 1 |
| Alborzi, N | 1 |
| Sadani, S | 1 |
| Keshtkar, AA | 1 |
| Usatine, RP | 1 |
| Partap, R | 1 |
| Kaur, I | 2 |
| Chakrabarti, A | 1 |
| Kumar, B | 1 |
| Sandhu, K | 1 |
| Kanwar, AJ | 1 |
| Karakaş, M | 1 |
| Durdu, M | 1 |
| Memişoğlu, HR | 1 |
| Narang, T | 1 |
| Dogra, S | 1 |
| Miranda, KC | 1 |
| de Araujo, CR | 1 |
| Costa, CR | 1 |
| Passos, XS | 1 |
| de Fátima Lisboa Fernandes, O | 1 |
| do Rosário Rodrigues Silva, M | 1 |
| Yazdanpanah, MJ | 1 |
| Azizi, H | 1 |
| Suizi, B | 1 |
| Pantazidou, A | 1 |
| Tebruegge, M | 1 |
| Gupta, R | 1 |
| Thami, GP | 1 |
| Köse, O | 1 |
| Bhargava, P | 1 |
| Kuldeep, CM | 1 |
| Mathur, NK | 1 |
| Hernanz Hermosa, JM | 1 |
| Lázaro Ochaita, P | 1 |
| Amer, MA | 1 |
| Montero-Gei, F | 1 |
| Robles, ME | 1 |
| Suchil, P | 1 |
| Bhogal, CS | 1 |
| Singal, A | 1 |
| Baruah, MC | 1 |
| Farschian, M | 1 |
| Yaghoobi, R | 1 |
| Samadi, K | 1 |
| Faergemann, J | 2 |
| Rigopoulos, D | 1 |
| Katsambas, A | 1 |
| Antoniou, C | 1 |
| Polydorou, D | 1 |
| Vlachou, M | 1 |
| Stratigos, J | 1 |
2 reviews available for fluconazole and Tinea Versicolor
| Article | Year |
|---|---|
Recurrent tinea versicolor: treatment with itraconazole or fluconazole?
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Humans; Itraconazole; Recurrence; Tinea Versic | 2007 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Chil | 1995 |
13 trials available for fluconazole and Tinea Versicolor
| Article | Year |
|---|---|
Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study.
Topics: Administration, Cutaneous; Antifungal Agents; Chemistry, Pharmaceutical; Drug Carriers; Drug Deliver | 2018 |
Comparative clinical trial: fluconazole alone or associated with topical ketoconazole in the treatment of pityriasis versicolor.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Hair Pre | 2016 |
A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor.
Topics: Adolescent; Adult; Antifungal Agents; Bangladesh; Female; Fluconazole; Humans; Incidence; Itraconazo | 2009 |
Single-dose oral fluconazole versus topical clotrimazole in patients with pityriasis versicolor: A double-blind randomized controlled trial.
Topics: Adult; Antifungal Agents; Clinical Protocols; Clotrimazole; Double-Blind Method; Female; Fluconazole | 2010 |
Single-dose fluconazole versus itraconazole in pityriasis versicolor.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Fluconazole; Humans; Itraconazol | 2004 |
Oral fluconazole in the treatment of tinea versicolor.
Topics: Administration, Oral; Adult; Antifungal Agents; Drug Administration Schedule; Female; Fluconazole; H | 2005 |
Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Humans; Iran; Ketoconazole; Male; Surveys and Questio | 2007 |
Fluconazole versus itraconazole in the treatment of tinea versicolor.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Middle | 1995 |
Fluconazole in the treatment of tinea versicolor. Egyptian Fluconazole Study Group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Data Interpretation, Statistical; Egypt; Female; Flucona | 1997 |
Fluconazole vs. itraconazole in the treatment of tinea versicolor.
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluconazo | 1999 |
Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Child; Drug Administration Schedule; Fem | 2001 |
Fluconazole versus ketoconazole in the treatment of tinea versicolor.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Double-Blind Method; Drug Administration | 2002 |
Tinea versicolor treated with fluconazole shampoo.
Topics: Adolescent; Adult; Female; Fluconazole; Humans; Male; Middle Aged; Soaps; Tinea Versicolor | 1992 |
12 other studies available for fluconazole and Tinea Versicolor
| Article | Year |
|---|---|
Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor.
Topics: Antifungal Agents; Arthrodermataceae; Crop Protection; Drug Discovery; Fluconazole; Fungicides, Indu | 2018 |
Efficacy of modified Leeming-Notman media in a resazurin microtiter assay in the evaluation of in-vitro activity of fluconazole against Malassezia furfur ATCC 14521.
Topics: Antifungal Agents; Colorimetry; Culture Media; Dermatomycoses; Fluconazole; Humans; Malassezia; Micr | 2018 |
Pityriasis versicolor: a case of resistance to treatment.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconaz | 2014 |
Fixed drug eruption related to fluconazole.
Topics: Antifungal Agents; Axilla; Drug Eruptions; Facial Dermatoses; Fluconazole; Humans; Male; Tinea Versi | 2016 |
Variations in color.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Black People; Diagnosis, | 2003 |
Extensive pityriasis versicolor of the face.
Topics: Adolescent; Adult; Facial Dermatoses; Fluconazole; Humans; Male; Prognosis; Risk Assessment; Severit | 2004 |
Co-localization of Pityriasis versicolor and BT Hansen's disease.
Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Leprostatic Agents; Lepros | 2005 |
Antifungal activities of azole agents against the Malassezia species.
Topics: Antifungal Agents; Azoles; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Mal | 2007 |
Fixed drug eruption caused by itraconazole: Reactivity and cross reactivity.
Topics: Antifungal Agents; Cross Reactions; Drug Eruptions; Female; Fluconazole; Humans; Itraconazole; Middl | 2008 |
Tinea versicolor with generalized anhidrosis.
Topics: Adult; Antifungal Agents; Biopsy, Needle; Fluconazole; Humans; Hypohidrosis; Male; Tinea Versicolor | 1996 |
Treatment of pityriasis versicolor with a single dose of fluconazole.
Topics: Adult; Aged; Female; Fluconazole; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Tine | 1992 |
Activity of triazole derivatives against Pityrosporum orbiculare in vitro and in vivo.
Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Rabbits; Structure- | 1988 |